United States · 
What does 1315 Capital invest in?
1315 Capital invests most often at Series A (100% of the rounds on record), in sectors such as Longevity, E-health and Molecules.
1315 Capital highlights
- 01
1 rounds on record
- 02
Mostly Series A: 100% of its rounds
- 03
Sole investor in 1 rounds, median undisclosed
What they do
1315 Capital invests in commercial-stage healthcare companies across healthcare services, pharma/medtech products, pharma/medtech outsourcing, and health & wellness companies.From their own website
- Type
- Private equity (from a list, unverified)
- Cheque size
- Not stated
- Stages
- Series ASeries BGrowth
- Sectors
- LongevityE-healthMolecules
- Based in
- Philadelphia, United States
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first1 appearances
- 2015
1 round
- Oct
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration4 named
ACAdele Cirone OlivaSole Member of (i) the General Partner of the General Partner and (ii) the General Partner of the Managing Member of the Investment ManageriFiling they signed
BRBrian Richard SchwenkChief Financial Officer of the Investment ManageriFiling they signed
MMM Michael KobyPartneriForm ADV
MCMichael C KobyMember of the General Partner and the Investment ManageriFiling they signed
We also hold 31 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What the register says
From the firm's own filings with the SEC, which it must file accurately by law
$1.4Bassets it managesOct 2026
Registeredinvestment adviserfull reporting to the SEC
- Legal name
- 1315 Capital, LLC
- SEC number
- CRD 175292
Funds on its Form ADV
8 private funds, $1.1B in gross assets · filed Mar 2024
- 1315 Capital, L.P.Private equity70 investors$295M
- 1315 Capital II, L.P.Private equity77 investors$282M
- 1315 Capital III, L.P.Private equity60 investors$267M
- 1315 Capital Emerging Growth & Buyout, L.P.Private equity59 investors$119M
- 1315 Capital III Parallel, L.P.Private equity41 investors$113M
- 1315 Capital Emerging Growth & Buyout Parallel, L.P.Private equity36 investors$56M
- 1315 Capital AIV II, L.P.Private equity36 investors$3.0M
- 1315 Capital AIV, L.P.Private equity19 investors$843K
What they claim to have backed
From their own portfolio page (on their website)
1 of 2 we have independently watched raise
AjustCookiedatabase
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.